Bernhard Schmidt

Bernhard Schmidt

Auto-generated profile, based on publicly available information

Bernhard Schmidt

Department of Cellular Biochemistry, University of Göttingen, Humboldtallee 23, 37073 Göttingen, Germany

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2015 in The FEBS Journal
Verified
Journal Article
Closed access
PDF file
JPJianhe Peng
Jianhe Peng
SASarfaraz Alam
Sarfaraz Alam
KRKarthikeyan Radhakrishnan
Karthikeyan Radhakrishnan
MMMalaiyalam Mariappan
Malaiyalam Mariappan
MRMarkus Georg Rudolph
Markus Georg Rudolph
BSBernhard Schmidt
Bernhard Schmidt

1 July 2018 in Cell Reports
Verified
Journal Article
Open access
LSLars Schlotawa
Lars Schlotawa
MWMichaela Wachs
Michaela Wachs
OBOlaf Bernhard
Olaf Bernhard
FMFranz J. Mayer
Franz J. Mayer
TDThomas Dierks
Thomas Dierks
KRKarthikeyan Radhakrishnan
Karthikeyan Radhakrishnan
Multiple sulfatase deficiency (MSD) is a fatal, inherited lysosomal storage disorder characterized by reduced activities of all sulfatases in patients. Sulfatases require a unique post-translational modification of an active-site cysteine to formylglycine that is catalyzed by the formylglycine-generating enzyme (FGE). FGE mutations that affect intracellular protein stability determine residual enzyme activity and disease severity in MSD patients. Here, we show that protein disulfide isomerase (PDI) plays a pivotal role in the recognition and quality control of MSD-causing FGE variants. Overexpression of PDI reduces the residual activity of unstable FGE variants, whereas inhibition of PDI function rescues the residual activity of sulfatases in MSD fibroblasts. Mass spectrometric analysis of a PDI+FGE variant covalent complex allowed determination of the molecular signature for FGE recognition by PDI. Our findings highlight the role of PDI as a disease modifier in MSD, which may also be relevant for other ER-associated protein folding pathologies.